PolyCrystalline provides reliable solutions to optimise and control the crystallisation process of Active Pharmaceutical Ingredients for pharmaceutical companies, since 2005.
Our mission is to support our clients during drug development, helping them to reduce batch failure, avoiding costly crystallisation issues and overall offering greater confidence in drug quality during manufacturing. We can support you from early-phase drug discovery to kilogram supply.
We are a high performing cohesive team of trained chemists and analysts, with more than 10 years of experience in the development and optimization of APIs crystallization.
We care about results and innovation based on sound science and the use of modern technologies.
FDA inspected test facility for the analysis of pharmaceutical products.
Our analytical department is certified to work according to GMP by AIFA.
The GMP certification includes:
PolyCrystalLine received the authorization N°487/2016 from the Italian Ministry of Health for the study and chemical/physical analysis of controlled substances.